N. Androulakis

University Hospital of Heraklion — Greece

Medicine · Health Sciences

15h-index927citations36works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(21), Lung Cancer Treatments and Mutations(14), Colorectal Cancer Treatments and Studies(14), Lung Cancer Research Studies(9), Hepatocellular Carcinoma Treatment and Prognosis(5)

Publications36 total

A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial
British Journal of Cancer·2012· 56 citedOpen Access
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial.
PubMed·2012· 2 cited
P47 Capecitabine, oxaliplatin and bevacizumab as first line treatment for elderly patients with metastatic colorectal cancer: a multicenter phase II trial from Hellenic Oncology Research Group
Critical Reviews in Oncology/Hematology·2009· 1 cited
Prognostic value of Mini Nutritional Assessment (MNA) score in elderly lung-cancer patients
Critical Reviews in Oncology/Hematology·2008· 1 cited
CAPIRI (capecitabine, irinotecan) + bevacizumab vs FOLFIRI (folinic acid, 5 fluorouracil, irinotecan) + bevacizumab for the treatment of patients with metastatic colorectal cancer (mCRC): Interim analysis for safety of a randomized phase III trial
Journal of Clinical Oncology·2008· 6 cited
WITHDRAWN: Irinotecan plus Weekly 5-Fluorouracil and Leucovorin as Salvage Treatment for Patients with Metastatic Colorectal Cancer: A Phase II Trial
Digestive Diseases·2007· 2 citedOpen Access
Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy
Annals of Oncology·2006· 63 cited
O12 FOLFOXIRI versus FOLFIRI as first line treatment in metastatic colorectal cancer (MCC): a subgroup analysis for elderly patients of a multicenter randomized phase III trial from the Hellenic Oncology Research Group (HORG)
Critical Reviews in Oncology/Hematology·2006
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)
British Journal of Cancer·2006· 400 citedOpen Access
Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study
British Journal of Cancer·2005· 45 citedOpen Access
Combination of Irinotecan (CPT-11) plus 5-Fluorouracil and Leucovorin (FOLFIRI Regimen) as First Line Treatment for Elderly Patients with Metastatic Colorectal Cancer: A Phase II Trial
Oncology·2005· 62 cited
Front-Line Chemotherapy with Docetaxel and Gemcitabine Administered Every Two Weeks in Patients with Metastatic Breast Cancer: A Multicenter Phase II Study
Oncology·2004· 27 cited
ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program
Lung Cancer·2003· 33 cited
Announcement
Oncology·2003Open Access
Salvage Treatment of Metastatic Breast Cancer with Docetaxel and Carboplatin
Oncology·2003· 20 cited
Sequential administration of cisplatin–etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II study
Lung Cancer·2002· 15 cited
An explosive course of squamous cell penile cancer in an AIDS patient
Annals of Oncology·2002· 17 cited
First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study
European Journal of Cancer·2001· 52 cited
Salvage treatment with irinotecan and gemcitabine in breast cancer patients pretreated with taxanes and anthracyclines: a multicenter phase II study
European Journal of Cancer·2001· 1 cited
Oxaliplatin in Combination with Infusional 5-Fluorouracil and Leucovorin Every 2 Weeks as First-Line Treatment in Patients with Advanced Colorectal Cancer: A Phase II Study
Oncology·2001· 18 cited
page 1 of 2Next →

Frequent Co-authors

John Souglakos(20), D. Mavroudis(15), Ch. Kouroussis(13), George Samonis(13), S. Kakolyris(13), Stylianos Kakolyris(12), Sofia Agelaki(11), Kostas Kalbakis(10), N. Vardakis(9), Vassilis Georgoulias(9), C. Kourousis(9), N. Vardakis(9), L. Vamvakas(8), Dora Hatzidaki(7), K. Kalbakis(7), V. Georgoulias(6), A. Athanasiadis(5), Vassilis Georgoulias(5), Athanasios Pallis(5), V. Georgoulias(5)